• 17 Aug 2018

Q2 highlights: strong Alström data opening up multiple options. Partnering and investor interest growing

ProMetic Life Sciences | PLI | 0 0 1.3% | Mkt Cap: 1,075m

    • Derren Nathan

    • 7 pages

Biotechnology image


 
Biotechnology image


This week’s Q2 update and conference call by Prometic highlighted just how important a part one of the Company’s smallest investigational indications (Alström Syndrome) is playing in driving its partnering and clinical strategy. Why is this?


Sign up to access

Get access to our full offering from over 30 providers

Get access to our full offering from over 30 providers


Get Started
Already a member? Log in here

More Content

More Content

Balance sheet transformed. Bioseparations performing well. Sharp focus on value driving clinical priorities

Companies: ProMetic Life Sciences

Hybridan - Small Cap Wrap

Companies: AVG PRSM COG FISH FUM LRM NWF PLI SCH TMT AVCT BIDS AKR HCM

Rights offer terms confirmed. More pre-clinical data on fibrotic lung conditions for both Ryplazim & PBI 4050

Companies: ProMetic Life Sciences

Plasminogen fast-tracked

Companies: ProMetic Life Sciences

Losses down 16.8%. Significant additions to the Board. Plenty of clinical progress expected in H2.

Companies: ProMetic Life Sciences

Copyright © 2020 Research Tree | All Rights Reserved. | Terms of Service and Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Tools licensed and contents implemented and optimized by Digital Look Ltd.

DigitalLook |Web Financial Group

©1999-2013 – Digital Look Ltd. A Web Financial Group Company All rights reserved. Legal notice.

Top